Jonathan Carson

Sep 30, 2024 | bioprocessonline.com | Matthew Pillar |Jonathan Carson |Helen Luo

An AI Awakening With Profluent Bio's Hilary Eaton, Ph.D.Hilary Eaton, Ph.D. was a self-described AI skeptic, particularly regarding using the tool in drug discovery. Then, a series of professional and deeply personal life events and medical discoveries put her in a position to confront that skepticism head-on. On Business of Biotech, the Chief Business Officer at ProFluent Bio shares her story and makes a pragmatic case for the transformative value of AI to biotech builders.

Jan 22, 2024 | thenow.co | Jonathan Carson

By Jonathan Carson“For f*ck’s sake, that’s f*cken bullsh*t,” I yelled. “I just wanna pick up this f*cken table and smash it through the f*cken window!”After several days of intense stress, it just took one more bit of bad news for my emotional state to boil over. I could feel anger overcome me from one moment to the next. A powerful energy bounced around my body like a pin ball.

Jan 1, 2024 | bioprocessonline.com | Jonathan Carson

By Jonathan Carson Did you know that mitochondrial transplantation therapies have already been tried in humans and that there’s a firm rationale for this biomedical technology based on two decades of basic research in cells and in vivo? Mitochondrial transplantation, sometimes called “mitochondrial augmentation”, is frequently found together with the word “therapy”, indicating closely aligned ideation between this tech and clinical translation.

Aug 11, 2023 | cellandgene.com | Jonathan Carson

Get more Cell & Gene insight with our FREE newsletter By Jonathan Carson Did you know that mitochondrial transplantation therapies have already been tried in humans and that there’s a firm rationale for this biomedical technology based on two decades of basic research in cells and in vivo?